Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol
2. Apleway
3. Csg452
4. Deberza
5. Tofogliflozin Anhydrous
6. Tofogliflozin Hydrate
1. 903565-83-3
2. Csg 452
3. Tofogliflozin [inn]
4. Tofogliflozin Anhydrous
5. Csg-452
6. (3s,3'r,4's,5's,6'r)-5-[(4-ethylphenyl)methyl]-6'-(hydroxymethyl)spiro[1h-2-benzofuran-3,2'-oxane]-3',4',5'-triol
7. R-7201
8. 903565-83-3 (free)
9. 554245w62t
10. (1s,3'r,4's,5's,6'r)-6-(4-ethylbenzyl)-6'-(hydroxymethyl)-3',4',5',6'-tetrahydro-3h-spiro[isobenzofuran-1,2'-pyran]-3',4',5'-triol
11. Spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol,6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)-,(1s,3'r,4's,5's,6'r)-
12. Apleway
13. Deberza
14. Tofogliflozin Anyhydrous
15. Ro4998452
16. Ro-4998452
17. Unii-554245w62t
18. Tofogliflozin [mi]
19. Ec 619-989-0
20. Schembl903156
21. Tofogliflozin [who-dd]
22. Gtpl9395
23. Chembl2110731
24. Csg452;csg-452
25. Dtxsid90238097
26. Chebi:136041
27. Bdbm50396779
28. Zinc35826342
29. Db11824
30. Compound 16d [pmid: 22889351]
31. Ncgc00485920-01
32. Ac-31468
33. Q27261271
34. (1s,3'r,4's,5's,6'r)-6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)-spiro(isobenzofuran-1(3h), 2'-(2h)pyran)-3',4',5'-triol
35. (1s,3'r,4's,5's,6'r)-6-((4-ethylphenyl)methyl)-6'-(hydroxymethyl)-3',4',5',6'-tetrahydro-3h-spiro(2-benzofuran-1,2'-pyran)-3',4',5'-triol
Molecular Weight | 386.4 g/mol |
---|---|
Molecular Formula | C22H26O6 |
XLogP3 | 1.5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 386.17293854 g/mol |
Monoisotopic Mass | 386.17293854 g/mol |
Topological Polar Surface Area | 99.4 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 521 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Sodium-Glucose Transporter 2 Inhibitors
Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. (See all compounds classified as Sodium-Glucose Transporter 2 Inhibitors.)
Market Place
ABOUT THIS PAGE
89
PharmaCompass offers a list of Tofogliflozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tofogliflozin manufacturer or Tofogliflozin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tofogliflozin manufacturer or Tofogliflozin supplier.
PharmaCompass also assists you with knowing the Tofogliflozin API Price utilized in the formulation of products. Tofogliflozin API Price is not always fixed or binding as the Tofogliflozin Price is obtained through a variety of data sources. The Tofogliflozin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tofogliflozin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tofogliflozin, including repackagers and relabelers. The FDA regulates Tofogliflozin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tofogliflozin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tofogliflozin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tofogliflozin supplier is an individual or a company that provides Tofogliflozin active pharmaceutical ingredient (API) or Tofogliflozin finished formulations upon request. The Tofogliflozin suppliers may include Tofogliflozin API manufacturers, exporters, distributors and traders.
click here to find a list of Tofogliflozin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Tofogliflozin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tofogliflozin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tofogliflozin GMP manufacturer or Tofogliflozin GMP API supplier for your needs.
A Tofogliflozin CoA (Certificate of Analysis) is a formal document that attests to Tofogliflozin's compliance with Tofogliflozin specifications and serves as a tool for batch-level quality control.
Tofogliflozin CoA mostly includes findings from lab analyses of a specific batch. For each Tofogliflozin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tofogliflozin may be tested according to a variety of international standards, such as European Pharmacopoeia (Tofogliflozin EP), Tofogliflozin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tofogliflozin USP).